BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16889636)

  • 21. Prospective assessment of fluoroquinolone use in a teaching hospital.
    Méan M; Pavese P; Vittoz JP; Foroni L; Decouchon C; Stahl JP; François P
    Eur J Clin Microbiol Infect Dis; 2006 Dec; 25(12):757-63. PubMed ID: 17072574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a 5-year antimicrobial stewardship program focusing on fluoroquinolone prescriptions.
    Pédeboscq S; Issa N; Lahouati M; Labadie A; Pereyre S; Camou F
    Int J Pharm Pract; 2021 Dec; 29(6):616-621. PubMed ID: 34355739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in carbapenems.
    Kattan JN; Villegas MV; Quinn JP
    Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proper use of fluoroquinolones in hospitalized elderly patients: Realisation of a clinical audit in geriatric hospitals of Lyon University Hospital].
    Papailhau C; Gaujard S; Girard R; Bourguignon L; Mouchoux C
    Rev Med Interne; 2018 Jul; 39(7):551-556. PubMed ID: 29784465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of clinical audit on antibiotic prescribing in general dental practice.
    Chate RA; White S; Hale LR; Howat AP; Bottomley J; Barnet-Lamb J; Lindsay J; Davies TI; Heath JM
    Br Dent J; 2006 Nov; 201(10):635-41. PubMed ID: 17128233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and economic consequences of ventilator-associated pneumonia.
    Amin A
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S36-43. PubMed ID: 19619020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phamacoeconomic analysis of antibiotics use in the Clinical Center of Vojvodina].
    Stefan-Mikić S; Jovanović J; Jovanović N; Aleksić-Dordević M; Cvjetković D; Krajcir I
    Med Pregl; 2008; 61 Suppl 1():50-8. PubMed ID: 19248640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic prescription and surveillance].
    Grappin M; Portier H
    Rev Prat; 2006 May; 56(10):1119-27. PubMed ID: 16836210
    [No Abstract]   [Full Text] [Related]  

  • 30. A 3 year survey on the use of antibacterial agents in five Italian hospitals.
    Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N
    J Antimicrob Chemother; 2008 Apr; 61(4):953-8. PubMed ID: 18218639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relevance of fluoroquinolones prescriptions in medical service].
    Lo Presti C; Blaise A; Maestracci M; Larue M
    Rev Pneumol Clin; 2018 Dec; 74(6):458-466. PubMed ID: 30017751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.
    Fowler S; Webber A; Cooper BS; Phimister A; Price K; Carter Y; Kibbler CC; Simpson AJ; Stone SP
    J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic use optimization program in the largest Croatian university hospital--benefits of restrictions on unlimited antibiotic use.
    Likić R; Francetić I; Bilusić M; Erdeljić V; Makar-Ausperger K; Junacko C; Simić P
    Coll Antropol; 2007 Mar; 31(1):241-6. PubMed ID: 17598408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetrating the walls of drug-resistant bacteria: a statutory prescription to combat antibiotic misuse.
    Markow SB
    Georgetown Law J; 1998 Nov; 87(2):531-62. PubMed ID: 10346703
    [No Abstract]   [Full Text] [Related]  

  • 35. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics.
    Jankovic SM; Radonjic V
    J Infect; 2007 Nov; 55(5):480-1. PubMed ID: 17764746
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
    Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
    Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia.
    Hadi U; Duerink DO; Lestari ES; Nagelkerke NJ; Keuter M; Huis In't Veld D; Suwandojo E; Rahardjo E; van den Broek P; Gyssens IC;
    Clin Microbiol Infect; 2008 Jul; 14(7):698-707. PubMed ID: 18558943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
    Jónsdóttir K; Kristinsson KG
    Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.